Last update 15 Jun 2026

Hualan Genetic Engineering (Henan) Co.,Ltd

Subsidiary Company|2022|Henan Sheng, China

Overview

Related

3
Clinical Trials associated with Hualan Genetic Engineering (Henan) Co.,Ltd
CTR20261374
/ RecruitingPhase 1
多中心、开放、剂量递增和扩大入组评价重组抗PD-L1和TGF-β双功能融合蛋白注射液在晚期复发或难治性恶性实体瘤参与者中的安全性、耐受性和初步疗效的Ⅰ期临床研究
[Translation] A multicenter, open-label, dose-escalation, and expanded-enrollment phase I clinical study evaluating the safety, tolerability, and preliminary efficacy of recombinant anti-PD-L1 and TGF-β bifunctional fusion protein injection in participants with advanced relapsed or refractory malignant solid tumors.
CTR20260125
/ RecruitingPhase 1
一项评估HL17在复发或难治性多发性骨髓瘤受试者中的安全性、耐受性、药代动力学和初步有效性的I期、开放标签、多中心研究
[Translation] A phase I, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of HL17 in patients with relapsed or refractory multiple myeloma.
CTR20251941
/ Active, not recruitingPhase 1
单中心、随机、双盲、单剂量、平行比较地舒单抗注射液（HL05-2）与普罗力®在健康男性参与者中药代动力学相似性和安全性的Ⅰ期临床研究
[Translation] A single-center, randomized, double-blind, single-dose, parallel phase I clinical study comparing the pharmacokinetic similarity and safety of denosumab injection (HL05-2) and Prolix® in healthy male participants
100 Clinical Results associated with Hualan Genetic Engineering (Henan) Co.,Ltd
Login to view more data
0 Patents (Medical) associated with Hualan Genetic Engineering (Henan) Co.,Ltd
Login to view more data
100 Deals associated with Hualan Genetic Engineering (Henan) Co.,Ltd
Login to view more data
100 Translational Medicine associated with Hualan Genetic Engineering (Henan) Co.,Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 04 Jul 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
2
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free